EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Potential for Extracellular Vesicles in Nanomedicine: A Review of Recent Advancements and Challenges Ahead

Farbod Ebrahimi, Anjali Kumari, Samaneh Ghadami, Saqer Al Abdullah, Kristen Dellinger iD

Advanced Biology · 2025

DOI: 10.1002/adbi.202400623 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Biology, 2025. Verfasst von Farbod Ebrahimi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nanoengineering, Joint School of Nanoscience and Nanoengineering, North Carolina A&T State University, 2907 E Gate City Blvd, Greensbor…. Hauptthemen laut MEDLINE: Extracellular Vesicles, Nanomedicine. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 245 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, Directorate for Engineering, National Institute of General Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extracellular vesicles (EVs) have emerged as promising tools in diagnostics and therapy for chronic diseases, including cancer and Alzheimer's. Small EVs, also called exosomes, are lipid‐bound particles (≈30–150 nm) that play a role in healthy and pathophysiological interactions, including intercellular communication, by transporting bioactive molecules, including proteins, lipids, and nucleic acids. Their ability to cross biological barriers, such as the blood‐brain barrier, makes them ideal candidates for targeted therapeutic interventions. In the context of chronic diseases, exosomes can be engineered to deliver active agents, including small molecules and siRNAs to specific target cells, providing a novel approach to precision medicine. Moreover, exosomes show great promise as repositories for diagnostic biomarkers. Their cargo can reflect the physiological and pathological status of the parent cells, making them valuable indicators of disease progression and response to treatment. This paper presents a comprehensive review of the application of exosomes in four chronic diseases: cancer, cardiovascular disease, neurodegenerative disease, and orthopedic disease, which significantly impact global public health due to their high prevalence and associated morbidity and mortality rates. Furthermore, the potential of exosomes as valuable tools for theranostics and disease management is highlighted. Finally, the challenges associated with exosomes and their demonstrated potential for advancing future nanomedicine applications are discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesNanomedicineHumansExosomesAnimalsNeoplasmsNeurodegenerative Diseases

Stichwörter der Autor:innen

biological nanoparticlesbiomarkerschronic diseasesdiagnosisexosomestherapy

Autor:innen und Institutionen

  • Department of Nanoengineering, Joint School of Nanoscience and Nanoengineering, North Carolina A&T State University, 2907 E Gate City Blvd, Greensboro, NC, 27401, USA.

ORCID-Profile: Kristen Dellinger

Förderung

  • NIGMS NIH HHS
  • Directorate for Engineering
  • National Institute of General Medical Sciences

Zitieren

APA

Ebrahimi, F., Kumari, A., Ghadami, S., Al Abdullah, S., & Dellinger, K. (2025). The Potential for Extracellular Vesicles in Nanomedicine: A Review of Recent Advancements and Challenges Ahead. Advanced Biology. https://doi.org/10.1002/adbi.202400623

Vancouver

Ebrahimi F, Kumari A, Ghadami S, Al Abdullah S, Dellinger K. The Potential for Extracellular Vesicles in Nanomedicine: A Review of Recent Advancements and Challenges Ahead. Advanced Biology. 2025. doi:10.1002/adbi.202400623

BibTeX
@article{Ebrahimi2025,
  author = {Ebrahimi, Farbod and Kumari, Anjali and Ghadami, Samaneh and Al Abdullah, Saqer and Dellinger, Kristen},
  title = {The Potential for Extracellular Vesicles in Nanomedicine: A Review of Recent Advancements and Challenges Ahead},
  journal = {Advanced Biology},
  year = {2025},
  doi = {10.1002/adbi.202400623}
}
Kostenlos starten →